Postpartum young women aged 45 years or younger with ER + breast cancer showed increased upregulation of transcription factors associated with cell cycle progression (E2F1 and E2F4), and downregulation of TP53 and ESR1, when compared with nulliparous women. The gene discussed is EREG; the disease is breast carcinoma.